Comparison of two adjuvant hormone therapy regimens in patients with high-risk localized prostate cancer after radical prostatectomy: primary results of study CU1005

The role of adjuvant hormonal therapy and optimized regimens for high-risk localized prostate cancer after radical prostatectomy remains controversial. Herein, the clinical trial CU1005 prospectively evaluated two regimens of maximum androgen blockage or bicalutamide 150 mg daily as immediate adjuva...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asian J Androl
Hauptverfasser: Chang, Kun, Qin, Xiao-Jian, Zhang, Hai-Liang, Dai, Bo, Zhu, Yao, Shi, Guo-Hai, Shen, Yi-Jun, Zhu, Yi-Ying, Ye, Ding-Wei
Format: Artigo
Sprache:Inglês
Veröffentlicht: Medknow Publications & Media Pvt Ltd 2016
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4854103/
https://ncbi.nlm.nih.gov/pubmed/26323560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.160884
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge